Pacira BioSciences Inc (PCRX)
26.24
+0.14
(+0.54%)
USD |
NASDAQ |
Apr 19, 16:00
26.24
0.00 (0.00%)
After-Hours: 16:20
Pacira BioSciences Gross Profit (Quarterly): 133.55M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 133.55M |
September 30, 2023 | 124.18M |
June 30, 2023 | 121.26M |
March 31, 2023 | 111.32M |
December 31, 2022 | 110.04M |
September 30, 2022 | 116.79M |
June 30, 2022 | 118.78M |
March 31, 2022 | 121.92M |
December 31, 2021 | 120.19M |
September 30, 2021 | 93.07M |
June 30, 2021 | 100.34M |
March 31, 2021 | 87.68M |
December 31, 2020 | 95.68M |
September 30, 2020 | 87.49M |
June 30, 2020 | 53.20M |
March 31, 2020 | 75.95M |
December 31, 2019 | 90.52M |
September 30, 2019 | 82.38M |
June 30, 2019 | 77.40M |
March 31, 2019 | 64.01M |
December 31, 2018 | 71.14M |
September 30, 2018 | 64.38M |
June 30, 2018 | 63.19M |
March 31, 2018 | 51.72M |
December 31, 2017 | 57.78M |
Date | Value |
---|---|
September 30, 2017 | 49.11M |
June 30, 2017 | 47.12M |
March 31, 2017 | 44.70M |
December 31, 2016 | 49.28M |
September 30, 2016 | 25.20M |
June 30, 2016 | 46.59M |
March 31, 2016 | 45.20M |
December 31, 2015 | 49.89M |
September 30, 2015 | 46.31M |
June 30, 2015 | 40.22M |
March 31, 2015 | 40.74M |
December 31, 2014 | 42.82M |
September 30, 2014 | 31.66M |
June 30, 2014 | 27.21M |
March 31, 2014 | 18.54M |
December 31, 2013 | 15.19M |
September 30, 2013 | 8.468M |
June 30, 2013 | 6.927M |
March 31, 2013 | 0.196M |
December 31, 2012 | 0.778M |
September 30, 2012 | -0.801M |
June 30, 2012 | 5.659M |
March 31, 2012 | 1.309M |
December 31, 2011 | -2.368M |
September 30, 2011 | 0.599M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
53.20M
Minimum
Jun 2020
133.55M
Maximum
Dec 2023
101.14M
Average
100.34M
Median
Jun 2021
Gross Profit (Quarterly) Benchmarks
Dynavax Technologies Corp | 46.91M |
Arbutus Biopharma Corp | -- |
Chimerix Inc | 0.004M |
Karyopharm Therapeutics Inc | 32.26M |
FibroGen Inc | 21.73M |